These results indicate that not only low expression of CENP-E but also another molecular pathway, may be involved in the sensitivity and resistance to Compound A. Among 237 tumor cell lines, there are 25 GSK923295-resistant cell lines with no common characteristics (Wood et al., 2010). This evidence concerns the gene CENPE and neoplasm.